4D Molecular Therapeutics (FDMT) EPS (Basic) (2020 - 2026)
4D Molecular Therapeutics' (FDMT) quarterly EPS (Basic) came in at -$1.01 in Q1 2026, down 17.39% year-on-year from -$1.22 in Q1 2025, and down 401.71% on a QoQ basis from $0.33 in Q4 2025.
4D Molecular Therapeutics (FDMT) EPS (Basic) (2020 - 2026) Analysis & Trends
4D Molecular Therapeutics (FDMT) has 7 years of EPS (Basic) data on file, last reported at -$1.01 in Q1 2026.
- On a quarterly basis, EPS (Basic) fell 17.39% year-over-year to -$1.01 in Q1 2026; TTM through Mar 2026 was -$2.36, a 25.32% increase from a year earlier, with the FY2025 full-year figure at -$2.42, up 18.9% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$1.01, down from $0.33 in the prior quarter.
- Over the last five years, EPS (Basic) for FDMT reached as high as $0.33 in Q4 2025 and fell as low as -$1.01 in Q3 2025.
- Historically, EPS (Basic) has averaged -$0.74 across 5 years, with a median of -$0.83 in 2023.
- Across the five-year window, EPS (Basic) tumbled 225.16% in 2024 and soared 136.36% in 2025, its largest moves.
- Year by year, EPS (Basic) stood at -$0.85 in 2022, then gained by 2.52% to -$0.83 in 2023, then slipped by 11.61% to -$0.92 in 2024, then surged by 136.36% to $0.33 in 2025, then plunged by 401.71% to -$1.01 in 2026.
- Per Business Quant data, the three most recent EPS (Basic) figures were -$1.01 in Q1 2026, $0.33 in Q4 2025, and -$1.01 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | 4D Molecular Therapeutics | 691.54 Mn | 300.64 Mn | - | -1.01 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.01 |
| Dec 31, 2025 | 0.33 |
| Sep 30, 2025 | -1.01 |
| Jun 30, 2025 | -0.98 |
| Mar 31, 2025 | -0.86 |
| Dec 31, 2024 | -0.92 |
| Sep 30, 2024 | -0.79 |
| Jun 30, 2024 | -0.63 |
| Mar 31, 2024 | -0.66 |
| Dec 31, 2023 | -0.83 |
| Sep 30, 2023 | -0.24 |
| Jun 30, 2023 | -0.77 |
| Mar 31, 2023 | -0.88 |
| Dec 31, 2022 | -0.85 |
| Sep 30, 2022 | -0.79 |
| Jun 30, 2022 | -0.87 |
| Mar 31, 2022 | -0.82 |
| Dec 31, 2021 | -0.90 |
| Sep 30, 2021 | -0.82 |
| Jun 30, 2021 | -0.28 |